GB202002706D0 - Pbp3 binding bicyclic peptide ligands - Google Patents

Pbp3 binding bicyclic peptide ligands

Info

Publication number
GB202002706D0
GB202002706D0 GBGB2002706.6A GB202002706A GB202002706D0 GB 202002706 D0 GB202002706 D0 GB 202002706D0 GB 202002706 A GB202002706 A GB 202002706A GB 202002706 D0 GB202002706 D0 GB 202002706D0
Authority
GB
United Kingdom
Prior art keywords
pbp3
peptide ligands
bicyclic peptide
binding bicyclic
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2002706.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleTx Ltd
Original Assignee
BicycleTx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleTx Ltd filed Critical BicycleTx Ltd
Priority to GBGB2002706.6A priority Critical patent/GB202002706D0/en
Publication of GB202002706D0 publication Critical patent/GB202002706D0/en
Priority to PCT/GB2021/050491 priority patent/WO2021171029A1/en
Priority to EP21709780.7A priority patent/EP4110791A1/en
Priority to JP2022551274A priority patent/JP2023515567A/ja
Priority to CN202180030647.7A priority patent/CN115443285A/zh
Priority to US17/905,010 priority patent/US20230106511A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB2002706.6A 2020-02-26 2020-02-26 Pbp3 binding bicyclic peptide ligands Ceased GB202002706D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB2002706.6A GB202002706D0 (en) 2020-02-26 2020-02-26 Pbp3 binding bicyclic peptide ligands
PCT/GB2021/050491 WO2021171029A1 (en) 2020-02-26 2021-02-26 Pbp3 binding bicyclic peptide ligands
EP21709780.7A EP4110791A1 (en) 2020-02-26 2021-02-26 Pbp3 binding bicyclic peptide ligands
JP2022551274A JP2023515567A (ja) 2020-02-26 2021-02-26 Ｐｂｐ３結合二環式ペプチドリガンド
CN202180030647.7A CN115443285A (zh) 2020-02-26 2021-02-26 结合pbp3的双环肽配体
US17/905,010 US20230106511A1 (en) 2020-02-26 2021-02-26 Pbp3 binding bicyclic peptide ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2002706.6A GB202002706D0 (en) 2020-02-26 2020-02-26 Pbp3 binding bicyclic peptide ligands

Publications (1)

Publication Number Publication Date
GB202002706D0 true GB202002706D0 (en) 2020-04-08

Family

ID=70108251

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2002706.6A Ceased GB202002706D0 (en) 2020-02-26 2020-02-26 Pbp3 binding bicyclic peptide ligands

Country Status (6)

Country Link
US (1) US20230106511A1 (enExample)
EP (1) EP4110791A1 (enExample)
JP (1) JP2023515567A (enExample)
CN (1) CN115443285A (enExample)
GB (1) GB202002706D0 (enExample)
WO (1) WO2021171029A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Ｃｄ１３７に対して特異的な二環式ペプチドリガンド
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
JP2008220317A (ja) * 2007-03-15 2008-09-25 Meiji Seika Kaisha Ltd ペニシリン結合タンパク質（ｐｂｐ）３トランスペプチダーゼドメイン
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
JP2018521960A (ja) * 2015-04-28 2018-08-09 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） 酵素で活性化された第ＸＩＩ因子（ＦＸＩＩａ）の新規阻害剤
CN106591265B (zh) * 2016-08-18 2019-08-13 武汉职业技术学院 一种青霉素结合蛋白及其应用
GB201706477D0 (en) * 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
WO2019002842A1 (en) * 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
GB201912320D0 (en) * 2019-08-28 2019-10-09 Bicycletx Ltd PBP Binding Bicyclic Peptide Ligands

Also Published As

Publication number Publication date
JP2023515567A (ja) 2023-04-13
CN115443285A (zh) 2022-12-06
WO2021171029A1 (en) 2021-09-02
US20230106511A1 (en) 2023-04-06
EP4110791A1 (en) 2023-01-04

Similar Documents

Publication Publication Date Title
GB201912320D0 (en) PBP Binding Bicyclic Peptide Ligands
IL304241A (en) Heterotandem bicyclic peptide complexes
IL290089A (en) Heterotandem bicyclic peptide complexes
SI4464721T1 (sl) Heterotandemski biciklični peptidni kompleksi
GB201900526D0 (en) Bicyclic peptide ligands specific for caix
GB201900525D0 (en) Bicyclic peptide ligands specific for caix
IL304211A (en) Bicyclic peptide ligands against infections
GB202110463D0 (en) PBP3 binding bicyclic peptide ligands
GB202102666D0 (en) Pbp3 binding bicyclic peptide ligands
GB202011270D0 (en) Pbp3 binding bicyclic peptide ligands
GB202307762D0 (en) Pbp3 binding bicyclic peptide ligands
GB202302599D0 (en) PBP3 binding bicyclic peptide ligands
GB202211037D0 (en) PBP3 binding bicyclic peptide ligands
GB202207673D0 (en) PBP3 binding bicyclic peptide ligands
GB202202634D0 (en) PBP3 binding bicyclic peptide ligands
IL304207A (en) Bicyclic peptide ligands against infections
GB202003982D0 (en) Pbp3 binding bicyclic peptide ligards
GB202118137D0 (en) Bicyclic peptide ligands specific for IL-6
GB202112462D0 (en) Bicyclic peptide ligands specific for IL-6
GB202019990D0 (en) Bicyclic peptide ligands specific for il-6
GB202112507D0 (en) Bicyclic peptide ligands specific for psma
GB202013804D0 (en) Bicyclic peptide ligands specific for psma
GB202118152D0 (en) Bicyclic peptide ligands specific for TNFalpha
GB202313262D0 (en) Bicyclic peptide ligands specific for PSMA
GB202118154D0 (en) Bicyclic peptide ligands specific for VEGF

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)